We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
一名患有超罕见CPS1突变的儿童，得益于个性化CRISPR疗法，在6个月内幸存。了解基因工程和N-of-1平台的突破。
